A patient is prescribed ipratropium bromide and albuterol for the treatment of chronic obstructive pulmonary disease (COPD). The patient informs the nurse that he uses the ipratropium bromide for acute attacks. The nurse can conclude that which of the following is true?


• Ipratropium bromide alone should not be used for the treatment of acute bronchospams. Ipratropium bromide is an anticholinergic and is not as fast acting as albuterol, which is a short-acting beta-2 agonist.

• The patient should be instructed to use his albuterol for acute bronchospasms and his ipratropium bromide as a scheduled/maintenance medication.

• Ipratropium, in combination with a short-acting beta agonist, can be used in the treatment of acute bronchospasms.

• Incorrect: There is no indication that the patient does not have COPD or that he needs additional refills.

Visit our website for other NCLEX topics now!